BMS-986458 | BMS-986458 : Degrader (PROTAC) of BCL6
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)
Control Compounds
Chemical Information
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
BCL6
  • IC50:1.9 ± 0.8 nM
  • IC50:41 ± 12 nM
  • EC50:2.2 nM
  • GI50:0.6 nM
  • EC50:0.2 ± 0.1 nM
Degrader (PROTAC)
up to 100 nM

Selectivity

In Cell Selectivity Assessment
Potency Assay Off-Target:
In a panel of known CRBN neosubstrate assays, no degradation of CK1α, GSPT1, IKZF1, IZKF3, nor SALL4 ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
The selectivity of BMS-986458 was confirmed in a global proteomics study where BCL6 was the only sig ...

Potency
Cellular
In Vitro

BCL6

Mode of Action: Degrader (PROTAC)

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.5c03123

In Vivo Validations

Mouse
Dose: 1 mg/Kg
Route of delivery: Intravenous
Plasma half life: 1.1 h
Systemic clearance: 6.67 mL/min/Kg
Area Under the Curve:: 3.98 uM*h
Volume of Distribution at Steady-State: 0.51 L/Kg

DOI Reference: 10.1021/acs.jmedchem.5c03123

Dose: 30 mg/Kg
Route of delivery: Oral
Cmax: 24.9 ± 3.5 uM
Tmax: 0.5 ± 0 h
Area Under the Curve:: 75.6 ± 20.3 uM*h
Bioavailability: 53%

DOI Reference: 10.1021/acs.jmedchem.5c03123

Rat
Dose: 1 mg/Kg
Route of delivery: Intravenous
Plasma half life: 0.90 ± 0.07 h
Systemic clearance: 9.74 ± 2.10 mL/min/Kg
Area Under the Curve:: 2.80 ± 0.54 uM*h
Volume of Distribution at Steady-State: 0.28 ± 0.03 L/Kg

DOI Reference: 10.1021/acs.jmedchem.5c03123

Dose: 10 mg/Kg
Route of delivery: Oral
Cmax: 0.90 ± 0.07 uM
Tmax: 2.33 ± 0.58 h
Area Under the Curve:: 44.6 ± 4.4 uM*h
Bioavailability: ~100%

DOI Reference: 10.1021/acs.jmedchem.5c03123

Dog
Dose: 1 mg/Kg
Route of delivery: Intravenous
Plasma half life: 4.6 ± 1.7 h
Systemic clearance: 0.85 ± 0.34 mL/min/Kg
Area Under the Curve:: 35.4 ± 16.3 uM*h
Volume of Distribution at Steady-State: 0.3 ± 0.2 L/Kg

DOI Reference: 10.1021/acs.jmedchem.5c03123

Dose: 3 mg/Kg
Route of delivery: Oral
Cmax: 15.1 ± 3.7 uM
Tmax: 2.0 ± 1.8 h
Area Under the Curve:: 72.2 ± 15.1 uM*h
Bioavailability: 67%

DOI Reference: 10.1021/acs.jmedchem.5c03123

Chemical Information

Coming Soon...

Expert Reviews


(on 23 Feb 2026)
Cellular Use Rating
In Model Organisms
This is an excellent degrader with respect to potency, selectivity and in vivo activity.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria